Our cohort ́s main finding suggests that the application of antibiotics 30 days before or after therapy initiation is associated with a worse outcome, indicating a possible influence of the host-microbiome modulation on the outcome of PD-1/PD-L1-targeted immunotherapy in HCC. This evidence concerns the gene CD274 and hepatocellular carcinoma.